Navigation Links
Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
Date:2/22/2012

SAN DIEGO, Feb. 22, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Citi 2012 Global Healthcare Conference in New York on Wednesday, February 29, 2012 at 11:00 a.m. ET / 8:00 a.m. PT. Kurt Gustafson, Chief Financial Officer, Halozyme Therapeutics, will provide a corporate overview.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com, and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets HYLENEX® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock
2. Halozyme Announces Proposed Public Offering of Common Stock
3. ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
4. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
5. Halozyme Therapeutics to Present Data on PEGPH20 at the Upcoming 2011 EORTC-NCI-ASCO Annual Meeting
6. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
7. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
8. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
9. Halozyme Therapeutics to Present at Upcoming Financial Conferences
10. Halozyme Therapeutics to Present at the Wedbush 2011 Global Healthcare Conference on August 17
11. Halozymes Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... PITTSBURGH , July 27, 2015  Mylan N.V. (NASDAQ: ... extraordinary general meeting of shareholders in connection with its proposed ... at the Okura Hotel Amsterdam on Friday, Aug. 28, 2015 ... Among other agenda items at the extraordinary general meeting, Mylan ... 2:107a of the Dutch Civil Code, of the acquisition of ...
(Date:7/27/2015)... 27, 2015  The fairness of the proposed acquisition ... Jude Medical ("St. Jude") is the subject of an ... rights law firm.  The investigation is focusing on possible ... by the Board of Directors of THOR for agreeing ... 2015, the Company announced it had reached a definitive ...
(Date:7/27/2015)... 27, 2015  Array BioPharma Inc. (Nasdaq: ... the fourth quarter and full year of ... to discuss those results on Monday, August ... will lead the call.  Date:Monday, ... 507-2598Pass Code: 68380312 Webcast, including Replay and ...
Breaking Medicine Technology:Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 2Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 3Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 4Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 5Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 6Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 8Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 9Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 10WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders 2
(Date:7/28/2015)... , ... July 28, 2015 , ... A new study ... Easy Fibromyalgia, Study Says " sheds light on a possible new treatment option for ... two months of regular HBOT sessions, at least five per week, patients experienced a ...
(Date:7/28/2015)... ... 2015 , ... There has been much discussion in Washington, D.C. ... often overlooked is the over 740,000 miles of municipal sewer lines designed ... facilities. According to the American Society of Civil Engineers , the average age ...
(Date:7/28/2015)... ... July 28, 2015 , ... Please join us for the 5th Annual Step ... Center located at Gary Avenue and Lies Road in Carol Stream. All are welcome. ... awareness, and provide education and help to support individuals and families affected by a brain ...
(Date:7/28/2015)... AURORA, Colo. (PRWEB) , ... July 28, 2015 ... ... education provider to offer online RN to BSN cohorts for Geisinger ... The education partnership provides GHS diploma and associate degree prepared nurses with access ...
(Date:7/28/2015)... ... , ... Scientel is thrilled to announce that they been accepted ... McHenry Convention Center in San Jose, Ca. Scientel will be participating as a Silver ... and the industry’s first polymorphic database will address the critical need of efficiently storing ...
Breaking Medicine News(10 mins):Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 3Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 4Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 2Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 3
... and Amortization Increased ... 3.85% and 2.96%, Respectively, MEXICO CITY, ... "the Group"), one of the leading Mexican,distributors of pharmaceutical products, ... other products,announces its consolidated financial and operating results for the ...
... WASHINGTON, Feb. 26 The following is a,statement ... Tobacco-Free,Kids:, All Nebraska workplaces, including restaurants, bars ... 2009, thanks to,legislation overwhelmingly approved by the Legislature ... Dave Heineman. Governor Heineman and the,Legislature have delivered ...
... Schnitzer West announced today,that one of the country,s most ... in The Shops at The Bravern in downtown Bellevue ... meet the needs of approximately 2,300,Microsoft employees who will ... beginning this fall., DavidBartonGym will offer Barton,s world ...
... Over 200,of MemorialCare,s top leaders will participate in a ... for Humanity of Orange County. The,home will be renovated ... palsy and is confined to a wheelchair. Halls will ... be given a "makeover" with,upgrades throughout., (Photo: ...
... designed to enhance patient acceptance and ... ... a prescription,laxative product that treats acute and chronic constipation, may be ... MiraLAX(R) and generic PEG 3350 products. Marketed in the,U.S. by Cumberland ...
... for His Support of a New ... Playground, LAS ... social service agency, during a ceremonial session of,the Las Vegas City Council meeting. ... playground fundraising,efforts., Mayor Goodman was presented with a plaque of appreciation by ...
Cached Medicine News:Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 4Health News:Nebraska's New Smoke-Free Law is Historic Win for Health 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 3Health News:MemorialCare Sponsors Habitat for Humanity Santa Ana Home 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 3
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions...
Disposable Cannula Cuffless Tracheostomy Tubes...
Indications For Usage: ,For use with percutaneous tracheotomies...
Medicine Products: